ARCHIVES

Proflavine Bioassay Ineffective, NCI Says

This article is from The Cancer Letter archive.

Vol. 03 No. 28 | July 15, 1977

Download PDF Visit The Full Archive

Related Articles

RFA For Patient Compliance Study

September 26, 1980

Canadian NCI Plans Review Of National Breast Screening Study

February 24, 1995

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

In Brief: Harmon Eyre Heads Medical Affairs, Research As Third Member OF ACS National Office “Troika”

April 16, 1993

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

November 12, 2004

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013